MEK inhibition was associated with an increase in CD8+ T-cell infiltration of tumors, elevated interferon-gamma (IFN-γ) gene expression signatures, as well as a decreased presence of tumor-associated macrophages and regulatory T cells [6–8]. The gene discussed is MAP2K7; the disease is neoplasm.